The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis
Open accessPublished version of a preprint
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Somatic mutation of the protein phosphatase 2A (PP2A) Aα-subunit gene PPP2R1A is highly prevalent in high-grade endometrial carcinoma. The structural, molecular, and biological basis by which the most recurrent endometrial carcinoma–specific mutation site P179 facilitates features of endometrial carcinoma malignancy has yet to be fully determined. Here, we used a series of structural, biochemical, and biological approaches to investigate the impact of the P179R missense mutation on PP2A function. Enhanced sampling molecular dynamics simulations showed that arginine-to-proline substitution at the P179 residue changes the protein's stable conformation profile. A crystal structure of the tumor-derived PP2A mutant revealed marked changes in A-subunit conformation. Binding to the PP2A catalytic subunit was significantly impaired, disrupting holoenzyme formation and enzymatic activity. Cancer cells were dependent on PP2A disruption for sustained tumorigenic potential, and restoration of wild-type Aα in a patient-derived P179R-mutant cell line restored enzyme function and significantly attenuated tumorigenesis and metastasis in vivo. Furthermore, small molecule–mediated therapeutic reactivation of PP2A significantly inhibited tumorigenicity in vivo. These outcomes implicate PP2A functional inactivation as a critical component of high-grade endometrial carcinoma disease pathogenesis. Moreover, they highlight PP2A reactivation as a potential therapeutic strategy for patients who harbor P179R PPP2R1A mutations. Significance: This study characterizes a highly recurrent, disease-specific PP2A PPP2R1A mutation as a driver of endometrial carcinoma and a target for novel therapeutic development. See related commentary by Haines and Huang, p. 4009
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, W., Arroyo, J. D., Timmons, J. C., Possemato, R., & Hahn, W. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1103 · Cited by 159
RetractedCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Laio, A., & Gervasio, F. L. (2008) · Reports on Progress in Physics · doi:10.1088/0034-4885/71/12/126601 · Cited by 1,619
Large-scale discovery of novel genetic causes of developmental disorders
Study, T. D. D. D. (2015) · Nature · doi:10.1038/nature14135 · Cited by 1,124
Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme
Cho, U. S., & Xu, W. (2007) · Nature · doi:10.1038/nature05351 · Cited by 459
Self-citationGroves, M. R., Hanlon, N., Turowski, P., Hemmings, B. A., & Barford, D. (1999) · Cell · doi:10.1016/s0092-8674(00)80963-0 · Cited by 442
PP2A: the expected tumor suppressor
Janssens, V., Goris, J., & Van Hoof, C. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.004 · Cited by 426
PP2A holoenzyme assembly: In cauda venenum (the sting is in the tail)
Janssens, V., Longin, S., & Goris, J. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.12.004 · Cited by 390
Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins
Xing, Y., Xu, Y., Chen, Y., Jeffrey, P. D., Chao, Y., Lin, Z., Li, Z., Strack, S., Stock, J. B., & Shi, Y. (2006) · Cell · doi:10.1016/j.cell.2006.09.025 · Cited by 334
Identification of specific PP2A complexes involved in human cell transformation
Chen, W., Possemato, R., Campbell, K. T., Plattner, C. A., Pallas, D. C., & Hahn, W. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00026-1 · Cited by 325
Research works printed but not linked: 45
- Siegel, 2018, Cancer statistics, 2018, CA Cancer J Clin, 68, 7, 10.3322/caac.21442 · DOI · Paper page
- Hamilton, 2006, Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers, Br J Cancer, 94, 642, 10.1038/sj.bjc.6603012 · DOI · Paper page
- Remmerie, 2018, Targeted therapies in type II endometrial cancers: too little, but not too late, Int J Mol Sci, 19, 10.3390/ijms19082380 · DOI
- Cantrell, 2015, Uterine carcinosarcoma: a review of the literature, Gynecol Oncol, 137, 581, 10.1016/j.ygyno.2015.03.041 · DOI · Paper page
- Arend, 2011, Uterine carcinosarcoma, Curr Opin Oncol, 23, 531, 10.1097/CCO.0b013e328349a45b · doi:10.1097/cco.0b013e328349a45b
- Felix, 2011, Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers, Int J Gynecol Cancer, 21, 877, 10.1097/IGC.0b013e31821a62dd · DOI
- Zhao, 2013, Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma, Proc Natl Acad Sci U S A, 110, 2916, 10.1073/pnas.1222577110 · DOI · Paper page
- Cancer Genome Atlas Research Network, 2013, Integrated genomic characterization of endometrial carcinoma, Nature, 497, 67, 10.1038/nature12113 · DOI · Paper page
- Gibson, 2016, The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis, Nat Genet, 48, 848, 10.1038/ng.3602 · DOI · Paper page
- Cherniack, 2017, Integrated Molecular characterization of uterine carcinosarcoma, Cancer Cell, 31, 411, 10.1016/j.ccell.2017.02.010 · DOI · Paper page
- Ruediger, 2001, Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene, Oncogene, 20, 10, 10.1038/sj.onc.1204059 · DOI
- Jeong, 2016, Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway, Sci Rep, 6, 27391, 10.1038/srep27391 · DOI · Paper page
- Nagaraj, 2015, Critical role of Wnt/beta-catenin signaling in driving epithelial ovarian cancer platinum resistance, Oncotarget, 6, 23720, 10.18632/oncotarget.4690 · DOI · Paper page
- Takahashi, 2011, Development of a mouse model for lymph node metastasis with endometrial cancer, Cancer Sci, 102, 2272, 10.1111/j.1349-7006.2011.02099.x · DOI
- Otwinowski, 1997, Processing of X-ray diffraction data collected in oscillation mode, Methods Enzymol, 276, 307, 10.1016/S0076-6879(97)76066-X · DOI · Paper page
- McCoy, 2007, Phaser crystallographic software, J Appl Crystallogr, 40, 658, 10.1107/S0021889807021206 · DOI · Paper page
- Emsley, 2010, Features and development of Coot, Acta Crystallogr D Biol Crystallogr, 66, 486, 10.1107/S0907444910007493 · DOI · Paper page
- CCP4, 1994, The CCP4 suite: programs for protein crystallography, Acta Crystallogr D Biol Crystallogr, 50, 760, 10.1107/S0907444994003112 · DOI · Paper page
- Abagyan, 1994, ICM—A new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation, J Comput Chem, 15, 488, 10.1002/jcc.540150503 · DOI · Paper page
- Case, 2005, The Amber biomolecular simulation programs, J Comput Chem, 26, 1668, 10.1002/jcc.20290 · DOI · Paper page
- Maier, 2015, ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB, J Chem Theory Comput, 11, 3696, 10.1021/acs.jctc.5b00255 · DOI · Paper page
- Price, 2004, A modified TIP3P water potential for simulation with Ewald summation, J Chem Phys, 121, 10096, 10.1063/1.1808117 · DOI · Paper page
- Doerr, 2016, HTMD: high-throughput molecular dynamics for molecular discovery, J Chem Theory Comput, 12, 1845, 10.1021/acs.jctc.6b00049 · DOI · Paper page
- Harvey, 2009, ACEMD: accelerating biomolecular dynamics in the microsecond time scale, J Chem Theory Comput, 5, 1632, 10.1021/ct9000685 · DOI · Paper page
- Bonomi, 2009, Reconstructing the equilibrium Boltzmann distribution from well-tempered metadynamics, J Comput Chem, 30, 1615, 10.1002/jcc.21305 · DOI · Paper page
- Skliros, 2012, The importance of slow motions for protein functional loops, Phys Biol, 9, 014001, 10.1088/1478-3975/9/1/014001 · DOI
- Hess, 2008, GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation, J Chem Theory Comput, 4, 435, 10.1021/ct700301q · DOI · Paper page
- Dolinsky, 2004, PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations, Nucleic Acids Res, 32, W665, 10.1093/nar/gkh381 · DOI · Paper page
- Baker, 2001, Electrostatics of nanosystems: application to microtubules and the ribosome, Proc Natl Acad Sci U S A, 98, 10037, 10.1073/pnas.181342398 · DOI · Paper page
- McConechy, 2011, Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas, J Pathol, 223, 567, 10.1002/path.2848 · DOI · Paper page
- Shih, 2011, Somatic mutations of PPP2R1A in ovarian and uterine carcinomas, Am J Pathol, 178, 1442, 10.1016/j.ajpath.2011.01.009 · DOI
- Nagendra, 2012, PPP2R1A mutations are common in the serous type of endometrial cancer, Mol Carcinog, 51, 826, 10.1002/mc.20850 · DOI · Paper page
- Morris, 1992, Stereochemical quality of protein structure coordinates, Proteins, 12, 345, 10.1002/prot.340120407 · DOI · Paper page
- Velazquez, 2015, Dynamical role of phosphorylation on serine/threonine-proline Pin1 substrates from constant force molecular dynamics simulations, J Chem Phys, 142, 075102, 10.1063/1.4907884 · DOI
- Dugave, 2003, Cis-trans isomerization of organic molecules and biomolecules: implications and applications, Chem Rev, 103, 2475, 10.1021/cr0104375 · DOI · Paper page
- Lu, 2007, Prolyl cis-trans isomerization as a molecular timer, Nat Chem Biol, 3, 619, 10.1038/nchembio.2007.35 · DOI · Paper page
- Wedemeyer, 2002, Proline cis-trans isomerization and protein folding, Biochemistry, 41, 14637, 10.1021/bi020574b · DOI · Paper page
- Andreotti, 2003, Native state proline isomerization: an intrinsic molecular switch, Biochemistry, 42, 9515, 10.1021/bi0350710 · DOI · Paper page
- Zhang, 2009, PR55 alpha, a regulatory subunit of PP2A, specifically regulates PP2A-mediated beta-catenin dephosphorylation, J Biol Chem, 284, 22649, 10.1074/jbc.M109.013698 · DOI · Paper page
- Kastrinsky, 2015, Reengineered tricyclic anti-cancer agents, Bioorg Med Chem, 23, 6528, 10.1016/j.bmc.2015.07.007 · DOI · Paper page
- Hahn, 2002, Enumeration of the simian virus 40 early region elements necessary for human cell transformation, Mol Cell Biol, 22, 2111, 10.1128/MCB.22.7.2111-2123.2002 · DOI · Paper page
- Strack, 2004, Critical role for protein phosphatase 2A heterotrimers in mammalian cell survival, J Biol Chem, 279, 47732, 10.1074/jbc.M408015200 · DOI · Paper page
- Dudley, 2016, Microsatellite instability as a biomarker for PD-1 blockade, Clin Cancer Res, 22, 813, 10.1158/1078-0432.CCR-15-1678 · DOI · Paper page
- Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, 6, pl1, 10.1126/scisignal.2004088 · DOI · Paper page
- Cerami, 2012, The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov, 2, 401, 10.1158/2159-8290.CD-12-0095 · DOI · Paper page
Cited by
Selective PP2A enhancement through biased heterotrimer stabilization
Leonard, D., Huang, W., Izadmehr, S., O’Connor, C. M., Wiredja, D. D., Wang, Z., Zaware, N., Chen, Y., Schlatzer, D. M., Kiselar, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.038 · Cited by 176
“Interestingly, recurrent mutation of these residues (for example, P179, R183, S256, and R258) result in marked changes in the PP2A holoenzyme composition in cells (Haesen et al., 2016; O’Connor et al., 2019; Ruediger et al., 2011; Taylor et al., 2019).”
Self-citationModulation of Phosphoprotein Activity by Phosphorylation Targeting Chimeras (PhosTACs)
Chen, P.-H., Hu, Z., An, E., Okeke, I., Zheng, S., Luo, X., Gong, A., Jaime-Figueroa, S., & Crews, C. M. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00693 · Cited by 130
Hu, Z., Chen, P.-H., Li, W., Douglas, T., Hines, J., Liu, Y., & Crews, C. M. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c11706 · Cited by 98
Kauko, O., Imanishi, S. Y., Kulesskiy, E., Yetukuri, L., Laajala, T. D., Sharma, M., Pavic, K., Aakula, A., Rupp, C., Jumppanen, M., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011265 · Cited by 65
Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors
O’Connor, C. M., Leonard, D., Wiredja, D., Avelar, R. A., Wang, Z., Schlatzer, D., Bryson, B., Tokala, E., Taylor, S. E., Upadhyay, A., et al. (2020) · Oncogene · doi:10.1038/s41388-019-1012-2 · Cited by 48
Self-citation
Metadata
- Authors
- Taylor, S. E., O'Connor, C. M., Wang, Z., Shen, G., Song, H., Leonard, D., Sangodkar, J., LaVasseur, C., Avril, S., Waggoner, S., Zanotti, K., Armstrong, A. J., Nagel, C., Resnick, K., Singh, S., Jackson, M. W., Xu, W., Haider, S., DiFeo, A., & Narla, G.
- Venue
- Cancer Research
- Published
- 2019-08-15
- Volume
- 79
- Issue
- 16
- Pages
- 4242-4257
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2947070173
- Cited by
- 59
- References
- 20
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- NIH NCI (R01 CA181654, R01 CA197780, F30 CA224979)
- Department of Defense (OC150553)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis. https://app.cochat.ai/papers/10.1158/0008-5472.can-19-0218
- The paper
- Taylor, S. E., O'Connor, C. M., Wang, Z., Shen, G., Song, H., Leonard, D., Sangodkar, J., LaVasseur, C., Avril, S., Waggoner, S., Zanotti, K., Armstrong, A. J., Nagel, C., Resnick, K., Singh, S., Jackson, M. W., Xu, W., Haider, S., DiFeo, A., & Narla, G. (2019). The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis. Cancer Research. https://doi.org/10.1158/0008-5472.can-19-0218
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.